Evidence map›Paper›PMID 40226999›Full record

ArticleJournal of the American Chemical Society2025

After 75 Years, an Alternative to Edman Degradation: A Mechanistic and Efficiency Study of a Base-Induced Method for N-Terminal Peptide Sequencing.

Harnimarta Deol, Ava Raeisbahrami, Phuoc H T Ngo, Jagannath Swaminathan, Ophelia Papoulas, Edward M Marcotte, Eric V Anslyn

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Principles ofbioRxiv : the preprint server for biology · 2026
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Harnimarta DeolDepartment of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0003-2798-564X
Ava RaeisbahramiDepartment of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
Phuoc H T NgoDepartment of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
Jagannath SwaminathanErisyon Inc, Austin, Texas 78752, United States.
Ophelia PapoulasDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, United States.
Edward M MarcotteDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0001-8808-180X
Eric V AnslynDepartment of Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.ORCID 0000-0002-5137-8797

Funding

Proteomics and model organism humanization to decode human geneticsR35GM122480 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI EDWARD M MARCOTTE · 2017 to 2026
$5.4M
Facilitating the Chemistry of FluorosequencingR35GM149308 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI Eric V. Anslyn · 2023 to 2026
$1.5M
NIGMS NIH HHS R35 GM122480NIGMS NIH HHS R35 GM149308
6 · The paper itself

Abstract

The sequencing of peptides via N-terminal amino acid removal is a classic reaction termed Edman degradation. This method involves repeated treatment of the N-terminal amino group of a peptide with phenyl isothiocyanate (PITC), followed by treatment with trifluoroacetic acid. Spurred by the need for an alternative non-acid-based chemistry for next-generation protein sequencing technologies, we developed a base-induced N-terminal degradation method. Several N-terminal derivatization reagents carrying supernucleophiles were tested. After rounds of iterative designs, compound

Indexed as

PeptidesSequence Analysis, ProteinAmino AcidsAmino Acid SequenceAmino AcidsPeptides

Identifiers

PMID40226999
PMCPMC12721331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.